Expert: Drug industry consolidation might add pressure to distributors

03/9/2009 | CNNMoney

Recent Big Pharma merger agreements including Pfizer and Wyeth's pending union and Merck & Co.'s planned acquisition of Schering-Plough are giving companies more leverage in their fee-for-service negotiations with distributors, a supply chain expert said. "In general, the consolidation of manufacturers is bad for wholesalers because it's giving the drug makers much more leverage in their fee-for-service negotiations," said Pembroke Consulting President and NAW Institute for Distribution Excellence Fellow Adam J. Fein, Ph.D.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Regional Buyer
Total Wine & More
Potomac, Maryland
Media Manager
Neiman Marcus
New York, New York
Senior Account Executive
New York, New York
Ralph Lauren
Lyndhurst, New Jersey
Marketing Campaign Planner: Bloomingdale's, New York, NY
New York, New York